Case Presentation

26
Case Presentation Dr Mohan Shenoy Consultant Paediatric Nephrologist Royal Manchester Children’s Hospital

description

Case Presentation. Dr Mohan Shenoy Consultant Paediatric Nephrologist Royal Manchester Children’s Hospital. History. 6yr girl Presents with non blanching palpable purpuric rash over extensor surface of arms and legs Ankle pain. Examination. Well child BP 106/60 Urine – NAD. - PowerPoint PPT Presentation

Transcript of Case Presentation

Page 1: Case Presentation

Case Presentation

Dr Mohan ShenoyConsultant Paediatric Nephrologist

Royal Manchester Children’s Hospital

Page 2: Case Presentation

History• 6yr girl

• Presents with non blanching palpable purpuric rash over extensor surface of arms and legs

• Ankle pain

Page 3: Case Presentation

Examination• Well child

• BP 106/60

• Urine – NAD

Page 4: Case Presentation

HSP: Background• Most common childhood vasculitis

• Incidence of HSP: 135-200 pmcp

• Highest among 4-6 year olds – 700 pmcp

Stewart M et al, Eur J Pediatr 147:113-115, 1988Gardner-Medwin J et al, Lancet 360:1197-202, 2002

Page 6: Case Presentation

Evaluation of a child with HSP• Weight• Blood pressure• Urine dipstix for blood and protein

• If dipstix positve for blood or protein:– Urine microscopy– Urine protein creatinine ratio– U&E, LFT

Page 7: Case Presentation

InvestigationsOnly if diagnosis uncertain

• FBC• Coagulation• ASO titre• C3 and C4• Igs• ANA, ANCA

Page 8: Case Presentation

Case history• So…

• In our patient with HSP with no renal manifestation, what follow-up and monitoring is required?

Page 9: Case Presentation

HSP – Onset of nephritisTime of onset of urinary abnormalities after the

diagnosis of HSP

Weeks after HSP diagnosis1 2 4 6 8 24

% 37 54 84 90 91 97

Narchi H Arch Dis Child 90:916-20, 2005

Page 11: Case Presentation

Can early steroid therapy prevent onset of HSP

nephritis?

Page 12: Case Presentation

Early steroids to prevent onset of HSP nephritis

• A large UK prospective study

• 353 children randomised to steroids or placebo

• No difference in the incidence of proteinuria at 12 months– 19/145 steroid vs 15/145 placebo

Dudley J et al Pediatr Nephrol 22:1457, 2007

Page 13: Case Presentation

Cochrane review 2009

Page 14: Case Presentation

Therefore…

Early steroid therapy to prevent onset of HSP nephritis cannot be recommended in children presenting with HSP

Page 15: Case Presentation

Case history• Child presents 3 weeks later

– Frank haematuria– Protein +++– BP 110/70– Not oedematous– Creat 45, albumin 34– Urine protein creatinine ratio 285mg/mmol

Page 16: Case Presentation

HSPN - Presentation

22%

43%

15%

20% Hematuria

Haematuria+proteinuriaNephritic

Nephrotic+nephritic

Page 17: Case Presentation

Indications for Renal Biopsy• Acute nephritis

• Nephrotic syndrome

• Persisting heavy proteinuria – Urine protein creatinine ratio >200mg/mmol

for 2 weeks

Page 18: Case Presentation

Discuss with Nephrologist• Hypertension

• Abnormal renal function

• Macroscopic haematuria > 5 days

• Persisting proteinuria

Page 19: Case Presentation

Case history• Weekly review

• Upcr improves 154 and then 75mg/mmol

• BP and creatinine normal

Page 20: Case Presentation

Prognosis of HSP nephritis• Significant variability

• Chronic kidney disease 2-20%

• 2% of children with ESKD in UK

Page 21: Case Presentation

Outcome of HSP nephritis • Unselected study

• 270 children with HSP over 13 years

• Renal involvement at presentation – 20%

• Mean follow-up 8.3 years

• CKD in only 3 (1.1%)

Stewart M et al, Eur J Pediatr 147:113-115, 1988

Page 22: Case Presentation

Clinical Presentation and Outcome

0

20

40

60

80

100

IHP NS AN AN &NS

ESKDActive diseaseMinor diseaseNormal

Cameron JS et al Oxford Textbook of Clinical Nephrology

Page 23: Case Presentation

Biopsy grade and Outcome

0

20

40

60

80

100

1 2 3 4 5

ESKDActive diseaseMinor diseaseNormal

ISKDC Biopsy grade

Cameron JS et al, Oxford Textbook of Clinical Nephrology

Page 24: Case Presentation

Long-term outcome of HSP nephritis

• 78 children with HSP nephritis• Various immunosuppressive regimens• F/U 23 years• Active renal disease: 7.5%• ESKD: 14%

Goldstein et al Goldstein et al Lancet 339:280–282Lancet 339:280–282, 1992, 1992

Page 25: Case Presentation

Outcome of HSP nephritis• 16/44 pregnancies – proteinuria+/-

hypertension

• 7 patients – deterioration following complete recovery at 5 year follow-up

Goldstein et al Goldstein et al Lancet 339:280–282Lancet 339:280–282, 1992, 1992

Page 26: Case Presentation

Take home messages• No risk of CKD if urinalysis normal at 6 months

• In unselected patients, the risk of CKD < 2%

• Presentation with acute nephritis and nephrotic syndrome high risk of CKD

• Late deterioration in renal function can occur and all children with significant nephritis require life long monitoring